Abstract
GEN EdgeVol. 5, No. 1 FinancingStockWatch: Top Biotech ETFs (Mostly) Sink Faster than the Market During Q1Apollomics tumbles after SPAC deal; Creative Medical Technology surges on diabetes data; Fast Track designation lifts SAB; TG jumps on sales forecastAlex PhilippidisAlex PhilippidisSearch for more papers by this authorPublished Online:14 Apr 2023https://doi.org/10.1089/genedge.5.1.59AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 5Issue 1Jan 2023 Information© 2023 by GEN PublishingTo cite this article:Alex Philippidis.StockWatch: Top Biotech ETFs (Mostly) Sink Faster than the Market During Q1.GEN Edge.Jan 2023.313-316.http://doi.org/10.1089/genedge.5.1.59Published in Volume: 5 Issue 1: April 14, 2023PDF download
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
